Welsh, P
Cezard, G
Gill, J M
Wallia, S
Douglas, A
Sheikh, A
Wild, S H
Tuomilehto, J
McKnight, J
Murray, G
Bhopal, R
Lean, M E
Sattar, N
Article History
Received: 12 August 2015
Revised: 11 December 2015
Accepted: 22 December 2015
First Online: 1 March 2016
Competing interests
: JT received research grants, served as a consultant to and/or a member of advisory boards for, and/or gave lectures organized by AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, ImpetoMedical, Merck, MSD, Sanofi-Aventis, Novartis, Novo Nordisk and Servier. The remaining authors declare no conflict of interest.